Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qidali (Jingfang Mixture) in Chronic Spontaneous Urticaria
CTR20221328Phase 2Completed
- Sponsor
- Lunan Houpu Pharmaceutical Co., Ltd.
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of jingfang mixture in chronic idiopathic urticaria (CIU), sponsored by Lunan Houpu Pharmaceutical Co., Ltd.. Started Jun 2022; status: completed.
02
Drugs
jingfang mixture
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on CTR20221328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221328.